Letter to the EditorEffects of the functioning and antipsychotic use on clinical high risk for psychosis: A response to Yung et al.
Section snippets
Contributors
Authors Jun Soo Kwon, Tae Young Lee, and Sung Nyun Kim were responsible for the design of the whole study and wrote the protocol. Authors Tae Young Lee and Myong-Wuk Chon wrote the manuscript. All authors contributed to and approved the final manuscript.
Acknowledgment
This project was funded by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (Grant no. 2013R1A2A1A03071089).
References (10)
- et al.
Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice
Eur. Neuropsychopharmacol.
(2009) - et al.
Symptomatic and functional remission of subjects at clinical high risk for psychosis: a 2-year naturalistic observational study
Schizophr. Res.
(2014) - et al.
Moving beyond transition outcomes: meta-analysis of remission rates in individuals at high clinical risk for psychosis
Psychiatry Res.
(2013) - et al.
Transition to first episode psychosis in ultra high risk populations: Does baseline functioning hold the key?
Schizophr. Res.
(2013) - et al.
Pharmacological treatment in the early phase of bipolar disorders: what stage are we at?
Aust. N. Z. J. Psychiatr.
(2006)
Cited by (3)
Brain network characteristics separating individuals at clinical high risk for psychosis into normality or psychosis
2017, Schizophrenia ResearchCitation Excerpt :Active interventions, such as psychological, pharmacological, or nutritional aids, might delay or prevent transition to psychosis (Stafford et al., 2013). As stated in our previous paper (Lee et al., 2014), we provided intensive treatment including psychoeducation, cognitive-behavioral therapy and pharmacotherapy to individuals at CHR for quicker abatement of symptoms and more rapid remission from the high risk status. Thus, it was difficult to investigate the natural course of clinical status.
Cognitive predictors of transition and remission of psychosis risk syndrome in a child and adolescent sample: longitudinal findings from the CAPRIS study
2024, European Child and Adolescent PsychiatryMismatch Negativity Predicts Remission and Neurocognitive Function in Individuals at Ultra-High Risk for Psychosis
2020, Frontiers in Psychiatry